Adrenal crisis while on high-dose steroid treatment: what rheumatologist should consider?

Rheumatol Int. 2017 Apr;37(4):657-662. doi: 10.1007/s00296-016-3591-3. Epub 2016 Nov 1.

Abstract

Steroid treatment is commonly recommended for autoimmune disorders in rheumatology practice. While adrenal crisis may occur upon existence of an inducing factor in patients with known or unknown adrenal insufficiency as well as in those with a suppressed hypothalamic-pituitary-adrenal (HPA) axis due to chronic steroid use, addisonian crisis rarely develops in patients on supraphysiological doses of steroid and, when emerged, it might be very difficult to recognize. Here, we present a patient who developed adrenal crisis while receiving high-dose methylprednisolone treatment due to retroperitoneal fibrosis and we also discuss possible mechanisms with a brief literature review.

Keywords: Adrenal crisis; Corticosteroid therapy; Retroperitoneal fibrosis; Tuberculosis.

Publication types

  • Case Reports
  • Review

MeSH terms

  • Adrenal Insufficiency / chemically induced*
  • Adrenal Insufficiency / physiopathology
  • Glucocorticoids / administration & dosage
  • Glucocorticoids / adverse effects*
  • Glucocorticoids / therapeutic use
  • Humans
  • Hypothalamo-Hypophyseal System / diagnostic imaging
  • Hypothalamo-Hypophyseal System / drug effects*
  • Membrane Glycoproteins
  • Middle Aged
  • Pituitary-Adrenal System / drug effects*
  • Receptors, Interleukin-1
  • Rheumatologists

Substances

  • Glucocorticoids
  • Membrane Glycoproteins
  • Receptors, Interleukin-1
  • TIRAP protein, human